Chylomicrons are the 'orphans' of the lipoprotein family. Difficulty of measurement has impeded understanding of their metabolism. Plasma concentrations of chylomicrons and chylomicron remnants give no insight into the magnitude of substrate flux through these pathways. A defect in clearance of chylomicron remnants is probably an indication of a more generalized defect in lipoprotein metabolism. Accumulating evidence supports a relationship between abnormalities in the clearance from plasma of chylomicron remnants and accelerated progression of atherosclerosis. Methods using stable isotopes in appropriately formulated emulsions are providing valuable new information.
Introduction
Interest in chylomicron metabolism and especially CR (chylomicron remnants) continues to increase with growing evidence of their contribution to atherosclerosis. There are now numerous studies linking atherogenic markers or risk factors to defects in CR clearance. New methods of clinical measurements of CR have been developed and a number of intervention studies have been published documenting the effects of lipid-lowering drugs on CR metabolism. It has been demonstrated directly that CR are taken up by the artery wall. Appreciation that the lipid composition of lipoproteins regulates their metabolism allows the testing of specific hypotheses relating to chylomicron and CR clearance. Figure 1 summarizes current understanding of CR metabolism. The normal physiological function of CR is to return bile cholesterol to the liver by an enterohepatic circulation. The CR cholesterol is available for various functions in the liver, including, but apparently without specific targeting, resecretion by the bile canaliculi into bile. After hydrolysis of the CR cholesteryl esters by lysosomal enzymes, the resultant unesterified cholesterol appears freely miscible in the hepatocyte, and a considerable proportion is secreted from the liver into the plasma VLDL (very-low-density lipoprotein) pool. Furthermore, the residual triacylglycerols remaining in CR after lipoprotein lipase action are an important source of hepatic fatty acids, estimated to account for 73% of newly synthesized VLDL triacylglycerols in normal mice [1] .
Physiology of CR
The concept in general use is that CR form part of the 'exogenous pathway' of lipoprotein metabolism. This concept requires revision. Figure 1 illustrates the active entero-hepatic circulation of cholesterol, and in man each day bile secretions add approx. 1000 mg of cholesterol into the lumen of the intestine. Shedding of mucosal cells adds another approx. 300 mg [2] . As diet generally contains less than 500 mg per day, it is clear that the majority of the cholesterol that is transported in CR derives from the re-absorption of endogenous cholesterol. Figure 1 also shows the intersections of the enterohepatic pathway with the vasculosystemic ('endogenous') VLDL pathway, which competes for both lipolysis and receptor uptake with the chylomicron pathway. Defects in both pathways generally co-exist because of these intersections. Demonstration of a defect in CR metabolism consequently points to a defect in the VLDL pathway.
ApoB (apolipoprotein B) synthesis by the intestine is essential for chylomicron formation and the mature apoB48 protein is integrated with the lipid droplet structure. ApoB48 appears not to play any role in chylomicron or CR metabolism, indicated by the close similarities between the metabolism of lymph chylomicrons and of protein-free lipid emulsions formulated to mimic the lipid composition of chylomicrons [3] [4] [5] , or CR [6] [7] [8] [9] [10] . The intestine continues to secrete small apoB48-containing particles in the fasting state, and apoB48 is detectable in the blood plasma of normal fasting individuals. Chylomicron size has a significant but rather modest effect on clearance, whereas particle numbers have much greater effects, indicating that CR clearance can be readily saturated [3] .
Lipoprotein lipase and formation of CR
When chylomicrons pass with the blood circulation through the capillaries of tissues such as muscle and adipose tissue, their triacylglycerols are acted on by lipoprotein lipase. The surface of chylomicron particles comprises mostly phospholipids, especially phosphatidylcholine, but a small percentage of the surface is triacylglycerol and presumably is the site of lipoprotein lipase activity. Several polymorphisms of lipoprotein lipase have been identified, some of which are associated with dyslipidaemias and with premature coronary artery disease. The phenotype is unremarkable with respect to fasting plasma triacylglycerols, but some of the polymorphisms affect post-prandial triacylglycerol clearance [11] . Despite the extreme hypertriglyceridaemia, total absence of lipoprotein lipase activity is not associated with significant impairment of CR metabolism (Table 1) .
Tissue perfusion and chylomicron clearance
The importance of tissue perfusion in chylomicron metabolism is largely unappreciated. In non-exercising skeletal muscle, for example, most capillaries are not perfused. Blood flow through adipose tissue is dynamic, and decreases for example when the sympathetic nervous system is activated.
Frayn and his associates have demonstrated the variability and post-prandial responses in blood flow through subcutaneous abdominal adipose tissue [12] [13] [14] . In rats, the clearance rate of injected chylomicronlike emulsions was impaired by infusion of noradrenaline, whereas adrenaline accelerated clearance [15] . Only a combination of α-and β-adrenergic agonists was effective in reproducing the accelerating effects of adrenaline. Like noradrenaline, angiotensin II impaired chylomicron and CR clearance. Adrenaline uniquely promotes both lipolysis and CR removal by the liver, effects that cannot be reproduced by other vascular mediators [16] .
Ligands and receptors for CR clearance
It is beyond question that apoE is the most important ligand for remnant clearance. In animals where apoE has been eliminated by gene manipulation, the clearance of remnants is negligible [7, 17] . The analogous human condition, also known as Type III hyperlipoproteinaemia, is similarly associated with defective CR metabolism ( Table 1) . ApoCI [18] and apoCIII [19] [20] [21] interfere with the binding of apoEcontaining lipoproteins to receptors. It is not clear whether the effects of the C apolipoproteins are due to steric or electrostatic interference with ligand-receptor interaction or simply a result of competition with amphipathic sites of association with the lipoprotein surface.
Current evidence suggests that the LDL (low-density lipoprotein) receptor and LRP (LDL receptor-related protein) both contribute to CR clearance, with the LDL receptor normally predominant. However, in mice in which the LDL receptor is defective LRP plays an important role [8, 22] . The situation in humans, while unclear, indicates that LRP is also active, as the breath test for remnant clearance was not significantly impaired in subjects with defective LDL receptors [23] . CR appear firstly to be sequestrated into the hepatic sinusoids by association with HSPG (heparan sulphate proteoglycan) [22, 24] .
It is not widely appreciated that cholesterol, although constituting only about 1% of lipid mass, plays an essential role in the normal physiology of chylomicron clearance. The importance of cholesterol can be readily demonstrated when cholesterol is omitted from chylomicron-like lipid emulsions. Without cholesterol, triacylglycerol hydrolysis occurs, but the resultant remnant particle remains in the plasma [25] [26] [27] . Remnant-like emulsions incorporating no sterol or ineffective sterols can be shown to contain apoE, which presumably fails to attain the conformation necessary to bind to receptors when cholesterol is lacking, as binding to fibroblasts or HepG2 cells is abolished. In consequence, failure to incorporate cholesterol in injected emulsions invalidates the physiological relevance of investigations using the 'chylomicron-like emulsion' approach.
Methods of measurement of post-prandial lipid metabolism
What is the best measure of CR clearance from plasma or metabolism? Several approaches give some information but all suffer from limitations. Some obvious shortcomings are avoided with the more specific assays of apoB48 and RLPc (remnant lipoprotein cholesterol), but neither assay distinguishes between chylomicrons and remnants, and both give a static picture of what is a highly dynamic metabolic process.
The clearance of lymph chylomicrons can be mimicked by appropriately formulated lipid emulsions, and direct comparisons have established the similarity of plasma clearance between lymph chylomicrons and the model emulsions [3, 4, 6, 28] . With this method of injecting chylomicron-like emulsions, in normal humans the fractional clearance rate of the triacylglycerol component is approx. 0.05 min −1 while that of the cholesteryl ester component is approx. 0.025 min −1 . The value for plasma cholesteryl ester clearance is similar to that found with injected remnant-like emulsions labelled with 13 C (P.H. Barrett, G.F. Watts and T.G. Redgrave, unpublished work).
Compared with the injections of chylomicron-like emulsions, improved specificity can be achieved with emulsions formulated to mimic the composition of CR [5, [7] [8] [9] [10] . When [ 13 C]cholesteryl ester is incorporated into a remnant-like emulsion, the procedure can be linked to a breath test (Figure 2) [23] . The breath test is advantageous for nondestructive experiments in animals, and ideal for human clinical studies. When interpreting data from the breath test, it is important to recognize that two additional complications have been added. The breath test gives an integrated assessment of CR clearance and subsequent metabolism, but it is incapable of localizing the cause of any defect. The fractional clearance rate in normal humans for the breath test is an order of magnitude lower than measurements of plasma clearance, indicating that the events following trapping of CR in the hepatic sinusoids, i.e. endocytosis, hydrolysis and oxidation, are substantially slower than the initial plasma clearance. Ideally, the breath test should be accompanied by measurements of plasma 13 C at intervals during the first 1-2 h after injection to allow assignment of a flat breath test either to a defect in uptake by the liver or to subsequent internalization and metabolism. Table 1 summarizes current experience with the CR breath test. Compared with normal men and women, CR clearance is impaired in subjects with obesity, diabetes and insulin resistance associated with visceral obesity and hypertension in the metabolic syndrome, with likely overlap with disordered VLDL kinetics.
Conclusions
There remain many unanswered questions concerning chylomicron and CR metabolism. Why are there disparities between the various measures of CR metabolism? Do measurements of apoB48 or RLPc give sufficient information? What is the impact of interventions on CR metabolism? Is CR metabolism in humans more like that in mice, rats or rabbits? All species show significant differences. In rats and mice, CR metabolism is rapid, but both species lack CETP (cholesteryl ester transfer protein). In rabbits, where CR clearance is somewhat slower than in rats or mice, CETP is present, but LDL receptors mediate clearance exclusively, suggesting that LRP is less important in this species. In mice, sequestration of CR by HSPG is clearly important, but this appears not to be the case in rabbits. In humans, CETP is present, but the disparity between the rates of plasma clearance of CR and the subsequent hepatic metabolism of CR cholesteryl esters suggests that there is a significant delay between trapping and internalization of CR. In humans, LRP must play a significant role in CR clearance, at least as an alternative back-up pathway, since most studies do not find a major problem with CR clearance when LDL receptors are defective. For example in familial hypercholesterolaemia (Type II hyperlipoproteinaemia; Table 1 ) a defect in CR metabolism is not evident when measured by the breath test. It is conceivable that mutations affecting binding might affect CR clearance differently from mutations affecting internalization. Answers to these questions will emerge in due course, and will assist in deepening current understanding of how CR contribute to atherosclerosis.
